MultiPlan Corporation Stock

Equities

MPLN

US62548M1009

Business Support Services

Real-time Estimate Cboe BZX 10:15:04 2024-05-20 am EDT 5-day change 1st Jan Change
0.585 USD -0.73% Intraday chart for MultiPlan Corporation -7.44% -58.89%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 1.01B Sales 2025 * 1.07B Capitalization 380M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 0.38 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.36 x
P/E ratio 2024 *
-0.59 x
P/E ratio 2025 *
-3.66 x
Employees 2,800
Yield 2024 *
-
Yield 2025 *
-
Free-Float 48.88%
More Fundamentals * Assessed data
Dynamic Chart
MultiPlan Corporation Announces Resignation of Jeffrey A. Doctoroff as Executive Vice President, General Counsel and Corporate Secretary CI
Earnings Flash (MPLN) MULTIPLAN CORPORATION Reports Q1 Revenue $234.5M MT
Transcript : MultiPlan Corporation, Q1 2024 Earnings Call, May 08, 2024
MultiPlan Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
MultiPlan Corporation Reports Impairment Charges for the First Quarter Ended March 31, 2024 CI
MultiPlan Corporation Provides Earnings Guidance for the Second Quarter and Maintains Earnings Guidance for the Full Year 2024 CI
Transcript : MultiPlan Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 03:05 PM
MultiPlan Corporation Appoints Jerry Hogge as Chief Operating Officer CI
MultiPlan Names Jerry Hogge as COO MT
MultiPlan Corporation Appoints Jerry Hogge as Executive Vice President, Chief Operating Officer, Effective from March 11, 2024 CI
Transcript : MultiPlan Corporation, Q4 2023 Earnings Call, Feb 29, 2024
Tranche Update on MultiPlan Corporation's Equity Buyback Plan announced on February 28, 2023. CI
MultiPlan Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
MultiPlan Corporation Provides Earnings Guidance for the First Quarter and Full Year 2024 CI
Transcript : MultiPlan Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 01:30 PM
More news
1 day-0.73%
1 week-7.44%
Current month-8.90%
1 month+7.01%
3 months-49.40%
6 months-53.75%
Current year-58.89%
More quotes
1 week
0.55
Extreme 0.5501
0.71
1 month
0.53
Extreme 0.53
0.78
Current year
0.53
Extreme 0.53
1.46
1 year
0.53
Extreme 0.53
2.29
3 years
0.53
Extreme 0.53
9.69
5 years
0.53
Extreme 0.53
12.93
10 years
0.53
Extreme 0.53
12.93
More quotes
Managers TitleAgeSince
Director of Finance/CFO 58 21-11-28
Chairman 68 03-12-31
Chief Tech/Sci/R&D Officer 58 12-12-31
Members of the board TitleAgeSince
Director/Board Member 62 -
Director/Board Member 67 20-12-31
Director/Board Member 73 16-09-30
More insiders
Date Price Change Volume
24-05-20 0.5826 -1.14% 27 985
24-05-17 0.5893 -1.36% 1,675,838
24-05-16 0.5974 -5.01% 2,045,915
24-05-15 0.6289 +11.47% 2,522,893
24-05-14 0.5642 -11.79% 3,173,755

Delayed Quote Nyse, May 20, 2024 at 10:00 am EDT

More quotes
MultiPlan Corporation is a provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the United States healthcare industry. The Company interprets customer’s needs and customizes solutions that combine its payment and revenue integrity, network-based, analytics-based, and data and decision science services. Through its data and technology platform, the Company provides out-of-network cost management, payment and revenue integrity, data and decision science, business-to-business (B2B) healthcare payments and other services to the payors of healthcare, which are primarily health insurers and their administrative-services-only (ASO) platforms, self-insured employers, federal and state government-sponsored health plans and other health plan sponsors, and, indirectly, the plan members who are the consumers of healthcare services. The Company is a partner to over 700 healthcare payors, brokers, and others.
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
0.5893 USD
Average target price
0.7 USD
Spread / Average Target
+18.78%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW